We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0H1Q market cap is 84.36M. The company's latest EPS is SEK 0.1330 and P/E is 14.29.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Revenue | 52.2M | 50.85M | 107.58M | 94.28M | 104.51M |
Operating Income | -12.87M | -15.06M | 6.92M | 12.57M | 6.66M |
Net Income | -13.39M | -16.01M | 11.33M | 9.21M | 5.89M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Assets | 27.7M | 34.94M | 66.55M | 72.46M | 89.75M |
Total Liabilities | 25.52M | 26.19M | 46.87M | 43.02M | 54.32M |
Total Equity | 2.18M | 8.75M | 19.68M | 29.44M | 35.44M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Operating | -510k | -3.51M | 18.63M | 7.77M | -6.88M |
Investing | -818k | -609k | -2.73M | -6.7M | -6.15M |
Financing | 2.99M | 9.44M | -2.17M | -1.24M | -1.49M |
Market Cap | 84.36M |
Price to Earnings Ratio | 14.29 |
Price to Sales Ratio | 0.81 |
Price to Cash Ratio | 11.08 |
Price to Book Ratio | 2.38 |
Dividend Yield | - |
Shares Outstanding | 44.31M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | Ortivus Ab |
Address |
karlsrovagen 2d danderyd 182 17 |
Website | https://www.ortivus.com |
Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions